Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.

Michal Sieniawski; Jennifer Wilkinson; Dominic Culligan; John Davies; John Goodlad; Ruth Jarrett; Anne L. Lennard; Helen Lucraft; Tryfonia Mainou-Fowler; Pam McKay; Fiona Scott; Sudhir Tauro; Jo White; Stephen J. Proctor

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.

Michal Sieniawski
, Jennifer Wilkinson
, Dominic Culligan
, John Davies
, John Goodlad
, Ruth Jarrett
, Anne L. Lennard
, Helen Lucraft
, Tryfonia Mainou-Fowler
, Pam McKay
, Fiona Scott
, Sudhir Tauro
, Jo White
, Stephen J. Proctor

Research output: Contribution to journal › Book/Film/Article review › peer-review

Original language	English
Article number	2604
Journal	Blood
Volume	112
Issue number	11
Publication status	Published - 16 Nov 2008

Access to Document

http://www.bloodjournal.org/content/112/11/2604

Cite this

Sieniawski, M., Wilkinson, J., Culligan, D., Davies, J., Goodlad, J., Jarrett, R., Lennard, A. L., Lucraft, H., Mainou-Fowler, T., McKay, P., Scott, F., Tauro, S., White, J., & Proctor, S. J. (2008). Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group. Blood, 112(11), Article 2604. http://www.bloodjournal.org/content/112/11/2604

Sieniawski, Michal ; Wilkinson, Jennifer ; Culligan, Dominic et al. / Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group. In: Blood. 2008 ; Vol. 112, No. 11.

@article{018424c78b314beb87f46facd7efa48b,

title = "Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.",

author = "Michal Sieniawski and Jennifer Wilkinson and Dominic Culligan and John Davies and John Goodlad and Ruth Jarrett and Lennard, \{Anne L.\} and Helen Lucraft and Tryfonia Mainou-Fowler and Pam McKay and Fiona Scott and Sudhir Tauro and Jo White and Proctor, \{Stephen J.\}",

note = "Abstract at ASH (American Society of Hematology) meeting, 2008",

year = "2008",

month = nov,

day = "16",

language = "English",

volume = "112",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "11",

}

Sieniawski, M, Wilkinson, J, Culligan, D, Davies, J, Goodlad, J, Jarrett, R, Lennard, AL, Lucraft, H, Mainou-Fowler, T, McKay, P, Scott, F, Tauro, S, White, J & Proctor, SJ 2008, 'Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.', Blood, vol. 112, no. 11, 2604. <http://www.bloodjournal.org/content/112/11/2604>

Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group. / Sieniawski, Michal; Wilkinson, Jennifer; Culligan, Dominic et al.
In: Blood, Vol. 112, No. 11, 2604, 16.11.2008.

Research output: Contribution to journal › Book/Film/Article review › peer-review

TY - JOUR

T1 - Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.

AU - Sieniawski, Michal

AU - Wilkinson, Jennifer

AU - Culligan, Dominic

AU - Davies, John

AU - Goodlad, John

AU - Jarrett, Ruth

AU - Lennard, Anne L.

AU - Lucraft, Helen

AU - Mainou-Fowler, Tryfonia

AU - McKay, Pam

AU - Scott, Fiona

AU - Tauro, Sudhir

AU - White, Jo

AU - Proctor, Stephen J.

N1 - Abstract at ASH (American Society of Hematology) meeting, 2008

PY - 2008/11/16

Y1 - 2008/11/16

M3 - Book/Film/Article review

SN - 0006-4971

VL - 112

JO - Blood

JF - Blood

IS - 11

M1 - 2604

ER -

Sieniawski M, Wilkinson J, Culligan D, Davies J, Goodlad J, Jarrett R et al. Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group. Blood. 2008 Nov 16;112(11):2604.